leisure time -WSS

leisure time

author：entertainment 2025-09-27 12:48:42 - browse：51

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： PrEP can help anyone prevent HIV. Why do so few people take it?

knowledge

WSS

What Henrietta Lacks's story taught me about my role as a doctor

Statins reduce cardiovascular risk in people living with HIV

How should state employee insurance handle Wegovy?

PrEP can help anyone prevent HIV. Why do so few people take it?

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Massive project maps cells in human brain in unprecedented detail

leisure time

leisure time

knowledge

Apple is now the first public company to be valued at $3 trillion

4 missing after record

BioMarin wins approval for gene therapy to treat hemophilia A

Takeaways from AdvaMed, the largest medical devices conference

The cancer drug shortage isn’t new — and neither are the solutions

Humana CEO Bruce Broussard to step down in 2024

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves first blood sugar monitor without finger pricks

Virginia high school admissions case could be legal follow

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

focus

Novartis develops a rapidly manufactured CAR

Life sciences deals on track to hit lowest point since 2017

European regulators consider appeal over Amylyx ALS drug

Humana CEO Bruce Broussard to step down in 2024

Peter Marks talks Operation Warp Speed for Rare Diseases

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

hotspot

Wikipedia

knowledge

Wikipedia